 | • レポートコード：MRC2-11QY05151 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病性足潰瘍治療のグローバル市場について調査・分析したレポートです。種類別（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置）市場規模、用途別（病院、専門クリニック、介護センター、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病性足潰瘍治療の競争状況、市場シェア ・世界の糖尿病性足潰瘍治療市場：種類別市場規模 2015年-2020年（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置） ・世界の糖尿病性足潰瘍治療市場：種類別市場規模予測 2021年-2026年（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置） ・世界の糖尿病性足潰瘍治療市場：用途別市場規模 2015年-2020年（病院、専門クリニック、介護センター、外来外科センター） ・世界の糖尿病性足潰瘍治療市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、介護センター、外来外科センター） ・北米の糖尿病性足潰瘍治療市場分析：米国、カナダ ・ヨーロッパの糖尿病性足潰瘍治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病性足潰瘍治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病性足潰瘍治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病性足潰瘍治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：B. Braun Melsungen AG、Smith & Nephew, Inc.、Organogenesis, Inc.、Derma Sciences Inc.、Sigvaris Inc.、3M、Acelity L.P. Inc.、Innocoll Holdings plc.、SIGVARIS, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutic Market
The global Diabetic Foot Ulcer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diabetic Foot Ulcer Therapeutic Scope and Market Size
Diabetic Foot Ulcer Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Foot Ulcer Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Diabetic Foot Ulcer Therapeutic market is segmented into
Advance Wound Dressings
Skin Substitutes
Negative Pressure Wound Therapy Devices
Segment by Application, the Diabetic Foot Ulcer Therapeutic market is segmented into
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers
Regional and Country-level Analysis
The Diabetic Foot Ulcer Therapeutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Diabetic Foot Ulcer Therapeutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Diabetic Foot Ulcer Therapeutic Market Share Analysis
Diabetic Foot Ulcer Therapeutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diabetic Foot Ulcer Therapeutic business, the date to enter into the Diabetic Foot Ulcer Therapeutic market, Diabetic Foot Ulcer Therapeutic product introduction, recent developments, etc.
The major vendors covered:
B. Braun Melsungen AG
Smith & Nephew, Inc.
Organogenesis, Inc.
Derma Sciences Inc.
Sigvaris Inc.
3M
Acelity L.P. Inc.
Innocoll Holdings plc.
SIGVARIS, Inc.
1 Study Coverage
1.1 Diabetic Foot Ulcer Therapeutic Product Introduction
1.2 Market Segments
1.3 Key Diabetic Foot Ulcer Therapeutic Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Diabetic Foot Ulcer Therapeutic Market Size Growth Rate by Type
1.4.2 Advance Wound Dressings
1.4.3 Skin Substitutes
1.4.4 Negative Pressure Wound Therapy Devices
1.5 Market by Application
1.5.1 Global Diabetic Foot Ulcer Therapeutic Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Long-Term Care Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diabetic Foot Ulcer Therapeutic Market Size, Estimates and Forecasts
2.1.1 Global Diabetic Foot Ulcer Therapeutic Revenue 2015-2026
2.1.2 Global Diabetic Foot Ulcer Therapeutic Sales 2015-2026
2.2 Global Diabetic Foot Ulcer Therapeutic, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Diabetic Foot Ulcer Therapeutic Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Diabetic Foot Ulcer Therapeutic Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Diabetic Foot Ulcer Therapeutic Competitor Landscape by Players
3.1 Diabetic Foot Ulcer Therapeutic Sales by Manufacturers
3.1.1 Diabetic Foot Ulcer Therapeutic Sales by Manufacturers (2015-2020)
3.1.2 Diabetic Foot Ulcer Therapeutic Sales Market Share by Manufacturers (2015-2020)
3.2 Diabetic Foot Ulcer Therapeutic Revenue by Manufacturers
3.2.1 Diabetic Foot Ulcer Therapeutic Revenue by Manufacturers (2015-2020)
3.2.2 Diabetic Foot Ulcer Therapeutic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Diabetic Foot Ulcer Therapeutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Diabetic Foot Ulcer Therapeutic Revenue in 2019
3.2.5 Global Diabetic Foot Ulcer Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Diabetic Foot Ulcer Therapeutic Price by Manufacturers
3.4 Diabetic Foot Ulcer Therapeutic Manufacturing Base Distribution, Product Types
3.4.1 Diabetic Foot Ulcer Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diabetic Foot Ulcer Therapeutic Product Type
3.4.3 Date of International Manufacturers Enter into Diabetic Foot Ulcer Therapeutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetic Foot Ulcer Therapeutic Market Size by Type (2015-2020)
4.1.1 Global Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020)
4.1.2 Global Diabetic Foot Ulcer Therapeutic Revenue by Type (2015-2020)
4.1.3 Diabetic Foot Ulcer Therapeutic Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Diabetic Foot Ulcer Therapeutic Market Size Forecast by Type (2021-2026)
4.2.1 Global Diabetic Foot Ulcer Therapeutic Sales Forecast by Type (2021-2026)
4.2.2 Global Diabetic Foot Ulcer Therapeutic Revenue Forecast by Type (2021-2026)
4.2.3 Diabetic Foot Ulcer Therapeutic Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Diabetic Foot Ulcer Therapeutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Diabetic Foot Ulcer Therapeutic Market Size by Application (2015-2020)
5.1.1 Global Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020)
5.1.2 Global Diabetic Foot Ulcer Therapeutic Revenue by Application (2015-2020)
5.1.3 Diabetic Foot Ulcer Therapeutic Price by Application (2015-2020)
5.2 Diabetic Foot Ulcer Therapeutic Market Size Forecast by Application (2021-2026)
5.2.1 Global Diabetic Foot Ulcer Therapeutic Sales Forecast by Application (2021-2026)
5.2.2 Global Diabetic Foot Ulcer Therapeutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Diabetic Foot Ulcer Therapeutic Price Forecast by Application (2021-2026)
6 North America
6.1 North America Diabetic Foot Ulcer Therapeutic by Country
6.1.1 North America Diabetic Foot Ulcer Therapeutic Sales by Country
6.1.2 North America Diabetic Foot Ulcer Therapeutic Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Type
6.3 North America Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Application
7 Europe
7.1 Europe Diabetic Foot Ulcer Therapeutic by Country
7.1.1 Europe Diabetic Foot Ulcer Therapeutic Sales by Country
7.1.2 Europe Diabetic Foot Ulcer Therapeutic Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Type
7.3 Europe Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Diabetic Foot Ulcer Therapeutic by Region
8.1.1 Asia Pacific Diabetic Foot Ulcer Therapeutic Sales by Region
8.1.2 Asia Pacific Diabetic Foot Ulcer Therapeutic Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Type
8.3 Asia Pacific Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Application
9 Latin America
9.1 Latin America Diabetic Foot Ulcer Therapeutic by Country
9.1.1 Latin America Diabetic Foot Ulcer Therapeutic Sales by Country
9.1.2 Latin America Diabetic Foot Ulcer Therapeutic Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Type
9.3 Central & South America Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Diabetic Foot Ulcer Therapeutic by Country
10.1.1 Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales by Country
10.1.2 Middle East and Africa Diabetic Foot Ulcer Therapeutic Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Type
10.3 Middle East and Africa Diabetic Foot Ulcer Therapeutic Market Facts & Figures by Application
11 Company Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Corporation Information
11.1.2 B. Braun Melsungen AG Description and Business Overview
11.1.3 B. Braun Melsungen AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Products Offered
11.1.5 B. Braun Melsungen AG Related Developments
11.2 Smith & Nephew, Inc.
11.2.1 Smith & Nephew, Inc. Corporation Information
11.2.2 Smith & Nephew, Inc. Description and Business Overview
11.2.3 Smith & Nephew, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Products Offered
11.2.5 Smith & Nephew, Inc. Related Developments
11.3 Organogenesis, Inc.
11.3.1 Organogenesis, Inc. Corporation Information
11.3.2 Organogenesis, Inc. Description and Business Overview
11.3.3 Organogenesis, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Products Offered
11.3.5 Organogenesis, Inc. Related Developments
11.4 Derma Sciences Inc.
11.4.1 Derma Sciences Inc. Corporation Information
11.4.2 Derma Sciences Inc. Description and Business Overview
11.4.3 Derma Sciences Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Products Offered
11.4.5 Derma Sciences Inc. Related Developments
11.5 Sigvaris Inc.
11.5.1 Sigvaris Inc. Corporation Information
11.5.2 Sigvaris Inc. Description and Business Overview
11.5.3 Sigvaris Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Products Offered
11.5.5 Sigvaris Inc. Related Developments
11.6 3M
11.6.1 3M Corporation Information
11.6.2 3M Description and Business Overview
11.6.3 3M Sales, Revenue and Gross Margin (2015-2020)
11.6.4 3M Diabetic Foot Ulcer Therapeutic Products Offered
11.6.5 3M Related Developments
11.7 Acelity L.P. Inc.
11.7.1 Acelity L.P. Inc. Corporation Information
11.7.2 Acelity L.P. Inc. Description and Business Overview
11.7.3 Acelity L.P. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Products Offered
11.7.5 Acelity L.P. Inc. Related Developments
11.8 Innocoll Holdings plc.
11.8.1 Innocoll Holdings plc. Corporation Information
11.8.2 Innocoll Holdings plc. Description and Business Overview
11.8.3 Innocoll Holdings plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Products Offered
11.8.5 Innocoll Holdings plc. Related Developments
11.9 SIGVARIS, Inc.
11.9.1 SIGVARIS, Inc. Corporation Information
11.9.2 SIGVARIS, Inc. Description and Business Overview
11.9.3 SIGVARIS, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Products Offered
11.9.5 SIGVARIS, Inc. Related Developments
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Corporation Information
11.1.2 B. Braun Melsungen AG Description and Business Overview
11.1.3 B. Braun Melsungen AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Products Offered
11.1.5 B. Braun Melsungen AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Diabetic Foot Ulcer Therapeutic Market Estimates and Projections by Region
12.1.1 Global Diabetic Foot Ulcer Therapeutic Sales Forecast by Regions 2021-2026
12.1.2 Global Diabetic Foot Ulcer Therapeutic Revenue Forecast by Regions 2021-2026
12.2 North America Diabetic Foot Ulcer Therapeutic Market Size Forecast (2021-2026)
12.2.1 North America: Diabetic Foot Ulcer Therapeutic Sales Forecast (2021-2026)
12.2.2 North America: Diabetic Foot Ulcer Therapeutic Revenue Forecast (2021-2026)
12.2.3 North America: Diabetic Foot Ulcer Therapeutic Market Size Forecast by Country (2021-2026)
12.3 Europe Diabetic Foot Ulcer Therapeutic Market Size Forecast (2021-2026)
12.3.1 Europe: Diabetic Foot Ulcer Therapeutic Sales Forecast (2021-2026)
12.3.2 Europe: Diabetic Foot Ulcer Therapeutic Revenue Forecast (2021-2026)
12.3.3 Europe: Diabetic Foot Ulcer Therapeutic Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Diabetic Foot Ulcer Therapeutic Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Diabetic Foot Ulcer Therapeutic Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Diabetic Foot Ulcer Therapeutic Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Diabetic Foot Ulcer Therapeutic Market Size Forecast by Region (2021-2026)
12.5 Latin America Diabetic Foot Ulcer Therapeutic Market Size Forecast (2021-2026)
12.5.1 Latin America: Diabetic Foot Ulcer Therapeutic Sales Forecast (2021-2026)
12.5.2 Latin America: Diabetic Foot Ulcer Therapeutic Revenue Forecast (2021-2026)
12.5.3 Latin America: Diabetic Foot Ulcer Therapeutic Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Diabetic Foot Ulcer Therapeutic Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Diabetic Foot Ulcer Therapeutic Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Diabetic Foot Ulcer Therapeutic Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Diabetic Foot Ulcer Therapeutic Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Diabetic Foot Ulcer Therapeutic Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diabetic Foot Ulcer Therapeutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Diabetic Foot Ulcer Therapeutic Market Segments
Table 2. Ranking of Global Top Diabetic Foot Ulcer Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Diabetic Foot Ulcer Therapeutic Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Advance Wound Dressings
Table 5. Major Manufacturers of Skin Substitutes
Table 6. Major Manufacturers of Negative Pressure Wound Therapy Devices
Table 7. Global Diabetic Foot Ulcer Therapeutic Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Diabetic Foot Ulcer Therapeutic Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Diabetic Foot Ulcer Therapeutic Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Regions (2015-2020)
Table 11. Global Diabetic Foot Ulcer Therapeutic Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Diabetic Foot Ulcer Therapeutic Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Diabetic Foot Ulcer Therapeutic Sales Share by Manufacturers (2015-2020)
Table 14. Global Diabetic Foot Ulcer Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Diabetic Foot Ulcer Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutic as of 2019)
Table 16. Diabetic Foot Ulcer Therapeutic Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Diabetic Foot Ulcer Therapeutic Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Diabetic Foot Ulcer Therapeutic Price (2015-2020) (USD/Pcs)
Table 19. Diabetic Foot Ulcer Therapeutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Diabetic Foot Ulcer Therapeutic Product Type
Table 21. Date of International Manufacturers Enter into Diabetic Foot Ulcer Therapeutic Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 24. Global Diabetic Foot Ulcer Therapeutic Sales Share by Type (2015-2020)
Table 25. Global Diabetic Foot Ulcer Therapeutic Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Diabetic Foot Ulcer Therapeutic Revenue Share by Type (2015-2020)
Table 27. Diabetic Foot Ulcer Therapeutic Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 29. Global Diabetic Foot Ulcer Therapeutic Sales Share by Application (2015-2020)
Table 30. North America Diabetic Foot Ulcer Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 31. North America Diabetic Foot Ulcer Therapeutic Sales Market Share by Country (2015-2020)
Table 32. North America Diabetic Foot Ulcer Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country (2015-2020)
Table 34. North America Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 35. North America Diabetic Foot Ulcer Therapeutic Sales Market Share by Type (2015-2020)
Table 36. North America Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 37. North America Diabetic Foot Ulcer Therapeutic Sales Market Share by Application (2015-2020)
Table 38. Europe Diabetic Foot Ulcer Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Diabetic Foot Ulcer Therapeutic Sales Market Share by Country (2015-2020)
Table 40. Europe Diabetic Foot Ulcer Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country (2015-2020)
Table 42. Europe Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Diabetic Foot Ulcer Therapeutic Sales Market Share by Type (2015-2020)
Table 44. Europe Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Diabetic Foot Ulcer Therapeutic Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Diabetic Foot Ulcer Therapeutic Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Diabetic Foot Ulcer Therapeutic Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales Market Share by Application (2015-2020)
Table 54. Latin America Diabetic Foot Ulcer Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Diabetic Foot Ulcer Therapeutic Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Diabetic Foot Ulcer Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country (2015-2020)
Table 58. Latin America Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Diabetic Foot Ulcer Therapeutic Sales Market Share by Type (2015-2020)
Table 60. Latin America Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Diabetic Foot Ulcer Therapeutic Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Diabetic Foot Ulcer Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales Market Share by Application (2015-2020)
Table 70. B. Braun Melsungen AG Corporation Information
Table 71. B. Braun Melsungen AG Description and Major Businesses
Table 72. B. Braun Melsungen AG Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. B. Braun Melsungen AG Product
Table 74. B. Braun Melsungen AG Recent Development
Table 75. Smith & Nephew, Inc. Corporation Information
Table 76. Smith & Nephew, Inc. Description and Major Businesses
Table 77. Smith & Nephew, Inc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Smith & Nephew, Inc. Product
Table 79. Smith & Nephew, Inc. Recent Development
Table 80. Organogenesis, Inc. Corporation Information
Table 81. Organogenesis, Inc. Description and Major Businesses
Table 82. Organogenesis, Inc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Organogenesis, Inc. Product
Table 84. Organogenesis, Inc. Recent Development
Table 85. Derma Sciences Inc. Corporation Information
Table 86. Derma Sciences Inc. Description and Major Businesses
Table 87. Derma Sciences Inc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Derma Sciences Inc. Product
Table 89. Derma Sciences Inc. Recent Development
Table 90. Sigvaris Inc. Corporation Information
Table 91. Sigvaris Inc. Description and Major Businesses
Table 92. Sigvaris Inc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Sigvaris Inc. Product
Table 94. Sigvaris Inc. Recent Development
Table 95. 3M Corporation Information
Table 96. 3M Description and Major Businesses
Table 97. 3M Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. 3M Product
Table 99. 3M Recent Development
Table 100. Acelity L.P. Inc. Corporation Information
Table 101. Acelity L.P. Inc. Description and Major Businesses
Table 102. Acelity L.P. Inc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Acelity L.P. Inc. Product
Table 104. Acelity L.P. Inc. Recent Development
Table 105. Innocoll Holdings plc. Corporation Information
Table 106. Innocoll Holdings plc. Description and Major Businesses
Table 107. Innocoll Holdings plc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Innocoll Holdings plc. Product
Table 109. Innocoll Holdings plc. Recent Development
Table 110. SIGVARIS, Inc. Corporation Information
Table 111. SIGVARIS, Inc. Description and Major Businesses
Table 112. SIGVARIS, Inc. Diabetic Foot Ulcer Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. SIGVARIS, Inc. Product
Table 114. SIGVARIS, Inc. Recent Development
Table 115. Global Diabetic Foot Ulcer Therapeutic Sales Forecast by Regions (2021-2026) (K Pcs)
Table 116. Global Diabetic Foot Ulcer Therapeutic Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Diabetic Foot Ulcer Therapeutic Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Diabetic Foot Ulcer Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. North America: Diabetic Foot Ulcer Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Diabetic Foot Ulcer Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. Europe: Diabetic Foot Ulcer Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Diabetic Foot Ulcer Therapeutic Sales Forecast by Region (2021-2026) (K Pcs)
Table 124. Asia Pacific: Diabetic Foot Ulcer Therapeutic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Diabetic Foot Ulcer Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. Latin America: Diabetic Foot Ulcer Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Diabetic Foot Ulcer Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Middle East and Africa: Diabetic Foot Ulcer Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Diabetic Foot Ulcer Therapeutic Players
Table 133. Diabetic Foot Ulcer Therapeutic Customers List
Table 134. Diabetic Foot Ulcer Therapeutic Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetic Foot Ulcer Therapeutic Product Picture
Figure 2. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Type in 2020 & 2026
Figure 3. Advance Wound Dressings Product Picture
Figure 4. Skin Substitutes Product Picture
Figure 5. Negative Pressure Wound Therapy Devices Product Picture
Figure 6. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Specialty Clinics
Figure 9. Long-Term Care Centers
Figure 10. Ambulatory Surgical Centers
Figure 11. Diabetic Foot Ulcer Therapeutic Report Years Considered
Figure 12. Global Diabetic Foot Ulcer Therapeutic Market Size 2015-2026 (US$ Million)
Figure 13. Global Diabetic Foot Ulcer Therapeutic Sales 2015-2026 (K Pcs)
Figure 14. Global Diabetic Foot Ulcer Therapeutic Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Region (2015-2020)
Figure 16. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Region in 2019
Figure 17. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Region (2015-2020)
Figure 18. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Region in 2019
Figure 19. Global Diabetic Foot Ulcer Therapeutic Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Diabetic Foot Ulcer Therapeutic Revenue in 2019
Figure 21. Diabetic Foot Ulcer Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Type (2015-2020)
Figure 23. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Type in 2019
Figure 24. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Type (2015-2020)
Figure 25. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Type in 2019
Figure 26. Global Diabetic Foot Ulcer Therapeutic Market Share by Price Range (2015-2020)
Figure 27. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Application (2015-2020)
Figure 28. Global Diabetic Foot Ulcer Therapeutic Sales Market Share by Application in 2019
Figure 29. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Application (2015-2020)
Figure 30. Global Diabetic Foot Ulcer Therapeutic Revenue Market Share by Application in 2019
Figure 31. North America Diabetic Foot Ulcer Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Diabetic Foot Ulcer Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Diabetic Foot Ulcer Therapeutic Sales Market Share by Country in 2019
Figure 34. North America Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country in 2019
Figure 35. U.S. Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Diabetic Foot Ulcer Therapeutic Market Share by Type in 2019
Figure 40. North America Diabetic Foot Ulcer Therapeutic Market Share by Application in 2019
Figure 41. Europe Diabetic Foot Ulcer Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Diabetic Foot Ulcer Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Diabetic Foot Ulcer Therapeutic Sales Market Share by Country in 2019
Figure 44. Europe Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country in 2019
Figure 45. Germany Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Diabetic Foot Ulcer Therapeutic Market Share by Type in 2019
Figure 56. Europe Diabetic Foot Ulcer Therapeutic Market Share by Application in 2019
Figure 57. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Diabetic Foot Ulcer Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales Market Share by Region in 2019
Figure 60. Asia Pacific Diabetic Foot Ulcer Therapeutic Revenue Market Share by Region in 2019
Figure 61. China Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Diabetic Foot Ulcer Therapeutic Market Share by Type in 2019
Figure 84. Asia Pacific Diabetic Foot Ulcer Therapeutic Market Share by Application in 2019
Figure 85. Latin America Diabetic Foot Ulcer Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Diabetic Foot Ulcer Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Diabetic Foot Ulcer Therapeutic Sales Market Share by Country in 2019
Figure 88. Latin America Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country in 2019
Figure 89. Mexico Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Diabetic Foot Ulcer Therapeutic Market Share by Type in 2019
Figure 96. Latin America Diabetic Foot Ulcer Therapeutic Market Share by Application in 2019
Figure 97. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Diabetic Foot Ulcer Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Diabetic Foot Ulcer Therapeutic Revenue Market Share by Country in 2019
Figure 101. Turkey Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Diabetic Foot Ulcer Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Diabetic Foot Ulcer Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Diabetic Foot Ulcer Therapeutic Market Share by Type in 2019
Figure 108. Middle East and Africa Diabetic Foot Ulcer Therapeutic Market Share by Application in 2019
Figure 109. North America Diabetic Foot Ulcer Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Diabetic Foot Ulcer Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Diabetic Foot Ulcer Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Diabetic Foot Ulcer Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Diabetic Foot Ulcer Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Diabetic Foot Ulcer Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Diabetic Foot Ulcer Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Diabetic Foot Ulcer Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Diabetic Foot Ulcer Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Diabetic Foot Ulcer Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
糖尿病性足潰瘍治療薬の世界市場（～2026年） Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing br…- 糖尿病性足潰瘍・褥瘡の世界市場（～2026年） Diabetic foot ulcers, are most common chronic wounds in patients suffering from diabetes, and lack of proper treatment of the foot ulcers often lead to progression of the wound resulting in lower extremity / foot amputation. Pressure ulcers are often a cause of lack of movement of the patients, long…
- 糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…
- 高度創傷ケアの世界市場（～2026年） Advanced Wound Care products for the wound healing process are generally prescribed by clinicians after a visit to the doctor or hospital. Advanced Wound Care products generally includes film and foam dressings, hydrogels, alginates and hydrocolloids. Such products are largely focused on keeping the…
- 十二指腸潰瘍治療の世界市場（～2026年） Duodenal ulcer is a sore occurring in the upper area of the small intestine, the duodenum. Globally demand for duodenal ulcer treatment is expected to witness growth due to increasing prevalence of the disease. Market Analysis and Insights: Global Duodenal Ulcer Treatment Market The global Duodenal …